Health Condition 1: H010- Blepharitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients having signs and symptoms of Klinnavartma. 2.Patients in age group between 18 to 60 yrs will be selected irrespective of their sex, religion, socio-economic status. 3.Only those patients will be selected who are willing to give written consent.
Exclusion criteria
Exclusion criteria: 1.Patient having anyother known ocular pathology. 2.Any past or present history of ocular trauma. 3.Patients with k/c/o NLDBlock, Dacrocystitis, DM, HBsAg, HIV. 4.Patient having any contagious disease. 5.Patient recently under goes eye surgeries 6.One eyed patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy Vacha,Haridra,Shunthi Bidalaka in klinnaVartma With Reference To Squamous cell Blepharitis.Timepoint: Vacha,Haridra,Sunthi Bidalaka Once in morning for 7 days eye Ointment Chloramphenicol OD for 7 days follow up on 3th,5th,7th day Total study duration will be 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To review of literature related to klinna vartma with reference to Sqamous cell Blepharitis in ayurvedic Samhita & modern books. 2)To review of literature related to drug Vacha, Haridra, Shunthi & Kriyakalpa Bidalaka according to Ayurvedic Samhitas. 3)To Evaluate the Efficacy of chloramphenicol eye Ointment in klinna Vartma 4) To Compare the efficacy of Vacha, Haridra, Sunthi Bidalaka & Chloramphenicol eye Ointment in klinna Vartma 5)To observe adverse drug reaction, If anyTimepoint: Vacha,Haridra,Sunthi Bidalaka Once in morning for 7 days eye Ointment Chloramphenicol OD for 7 days follow up on 3th,5th,7th day Total study duration will be 18 months | — |
Countries
India
Contacts
PMTs Ayurved college and Shri Eknath Rugnalay, Shevgoan